Advertisement

Genes & Genomics

, Volume 41, Issue 4, pp 483–490 | Cite as

Promoter cross-talk affects the inducible expression of intronic shRNAs from the tetracycline response element

  • Seong Kyun Park
  • Byung Joon Hwang
  • Yun KeeEmail author
Research Article

Abstract

Background

RNA interference (RNAi), defined as double-stranded, RNA-mediated gene silencing, is a useful tool for functional genomic studies. Along with increasing information about genomic sequences due to the innovative development of genome-sequencing technologies, functional genomic technologies are needed to annotate the genome and determine the processes by which each gene is regulated. Lentiviral vectors have been used to efficiently deliver reagents, such as small interfering RNAs (siRNAs) and short hairpin RNAs (shRNAs), into cells and tissues for functional genomic analyses.

Objective

We developed a lentiviral vector that efficiently expresses intronic shRNA from the tetracycline regulatory element (TRE) promoter in a doxycycline-dependent manner.

Methods

We developed a lentiviral vector system that contains reverse tetracycline-controlled transactivator 3 (rtTA3) and the TRE promoter, which are necessary for the doxycycline-inducible expression of shRNAs that are expressed as intronic miR-30a precursors. We then measured the cross-talk between the cytomegalovirus (CMV) and TRE promoters in the vector.

Results

We found that nearby promoters influence each other and that the TRE promoter should be located far from other promoters, such as the CMV promoter, in a vector. The orientation of a promoter with respect to other promoters also influences its transcriptional activity. A head-to-head orientation of the CMV and TRE promoters maintains the lowest level of transcription from TRE in the absence of doxycycline, compared to the tail-to-tail and head-to-tail orientations.

Conclusion

Based on these findings, we were able to construct a lentiviral vector that faithfully expresses intronic miR-30a shRNA precursors in a doxycycline-inducible manner.

Keywords

Promoter cross-talk Tetracycline-inducible promoter Lentiviral vector ShRNA 

Notes

Acknowledgements

This work was supported by the Basic Science Research Program through the NRF by the Ministry of Education (Grant No. NRF-2015R1D1A3A01015641) and a grant from the National R&D Program for Cancer Control, Ministry of Health & Welfare, Republic of Korea (Grant No. HA17C0035) to B.J. Hwang, and both the SGER Program through the NRF by the Ministry of Education (Grant No. NRF-2015R1D1A1A02060346) and the 2015 Research Grant from Kangwon National University to Y. Kee.

Compliance with ethical standards

Conflict of interest

The authors declare no conflicts of interest.

Ethical approval

This article does not contain any studies with human participants or animals performed by any of the authors.

References

  1. Borchert GM, Lanier W, Davidson BL (2006) RNA polymerase III transcribes human microRNAs. Nat Struct Mol Biol 13:1097–1101CrossRefPubMedGoogle Scholar
  2. Czauderna F, Santel A, Hinz M et al (2003) Inducible shRNA expression for application in a prostate cancer mouse model. Nucl Acids Res 31:e127CrossRefPubMedGoogle Scholar
  3. Fire A, Xu S, Montgomery MK et al (1998) Potent and specific genetic interference by double-stranded RNA in caenorhabditis elegans. Nature 391:806–811CrossRefPubMedGoogle Scholar
  4. Giering JC, Grimm D, Storm TA, Kay MA (2008) Expression of shRNA from a tissue-specific pol II promoter is an effective and safe RNAi therapeutic. Mol Ther 16:1630–1636CrossRefPubMedGoogle Scholar
  5. Hammond SM, Bernstein E, Beach D, Hannon GJ (2000) An RNA-directed nuclease mediates post-transcriptional gene silencing in Drosophila cells. Nature 404:293–296CrossRefPubMedGoogle Scholar
  6. Kordower JH, Emborg ME, Bloch J et al (2000) Neurodegeneration prevented by lentiviral vector delivery of GDNF in primate models of Parkinson’s disease. Science 290:767–773CrossRefPubMedGoogle Scholar
  7. Lee Y, Kim M, Han J et al (2004) MicroRNA genes are transcribed by RNA polymerase II. EMBO J 23:4051–4060CrossRefPubMedPubMedCentralGoogle Scholar
  8. Levine BL, Humeau LM, Boyer J et al (2006) Gene transfer in humans using a conditionally replicating lentiviral vector. Proc Natl Acad Sci 103:17372–17377CrossRefPubMedGoogle Scholar
  9. Lin SL, Miller JD, Ying SY (2006) Intronic microRNA (miRNA). J. Biomed. Biotechnol. 2006:1–13CrossRefGoogle Scholar
  10. Lois C, Hong EJ, Pease S et al (2002) Germline transmission and tissue-specific expression of transgenes delivered by lentiviral vectors. Science 295:868–872CrossRefGoogle Scholar
  11. Manjunath N, Wu H, Subramanya S, Shankar P (2009) Lentiviral delivery of short hairpin RNAs. Adv Drug Deliv Rev 61:732–745CrossRefPubMedPubMedCentralGoogle Scholar
  12. Matsushita N, Matsushita S, Hirakawa S, Higashiyama S (2013) Doxycycline-dependent inducible and reversible rna interference mediated by a single lentivirus vector. Biosci Biotechnol Biochem 77:776–781CrossRefPubMedGoogle Scholar
  13. MD PSP, MD JMG, PhD GSR et al (2014) Long-term safety and tolerability of ProSavin, a lentiviral vector-based gene therapy for Parkinson’s disease: a dose escalation, open-label, phase 1/2 trial. Lancet 1–9Google Scholar
  14. Montini E, Cesana D, Schmidt M et al (2006) Hematopoietic stem cell gene transfer in a tumor-prone mouse model uncovers low genotoxicity of lentiviral vector integration. Nat Biotechnol 24:687–696CrossRefPubMedGoogle Scholar
  15. Moore CB, Guthrie EH, Huang MTH, Taxman DJ (2010) Short hairpin RNA (shRNA): design, delivery, and assessment of gene knockdown. Methods Mol Biol 629:141–158PubMedPubMedCentralGoogle Scholar
  16. Naldini L, Blömer U, Gallay P et al (1996) In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector. Science 272:263–267CrossRefPubMedGoogle Scholar
  17. Noguchi K, Ishitu Y, Miyano-Kurosaki N, Takaku H (2007) Expression of shRNA using intron splicing. Nucleic Acids Symp Ser 51:409–410CrossRefGoogle Scholar
  18. Noguchi K, Ishitu Y, Takaku H (2011) Evaluating target silencing by short hairpin RNA mediated by the group I intron in cultured mammalian cells. BMC Biotechnol 11:79CrossRefPubMedPubMedCentralGoogle Scholar
  19. Paddison PJ, Caudy AA, Bernstein E et al (2002) Short hairpin RNAs (shRNAs) induce sequence-specific silencing in mammalian cells. Genes Dev 16:948–958CrossRefPubMedPubMedCentralGoogle Scholar
  20. Pan X, Chen Z, Ni Q et al (2006) Application of PCR-based tRNAval Pol III-shRNA expression cassettes in screening of efficient siRNA for inhibiting hepatitis B virus. Zhejiang Da Xue Xue Bao Yi Xue Ban 35:154–160PubMedGoogle Scholar
  21. Pluta K, Kacprzak MM (2009) Use of HIV as a gene transfer vector. Acta Biochim Pol 56:531–595CrossRefPubMedGoogle Scholar
  22. Rangasamy D, Tremethick DJ, Greaves IK (2008) Gene knockdown by ecdysone-based inducible RNAi in stable mammalian cell lines. Nat Protoc 3:79–88CrossRefPubMedGoogle Scholar
  23. Silva JM, Li MZ, Chang K et al (2005) Second-generation shRNA libraries covering the mouse and human genomes. Nat Genet 37:1281–1288CrossRefPubMedGoogle Scholar
  24. Strebhardt, Matthess Y, Kaufmann M (2007) Silencing of mammalian genes by tetracycline- inducible shrna expression. Nat Protoc 2:3257–3269CrossRefPubMedGoogle Scholar
  25. Wiederschain D, Wee S, Chen L et al (2009) Single-vector inducible lentiviral RNAi system for oncology target validation. Cell Cycle 8:498–504CrossRefPubMedGoogle Scholar
  26. Xia XG, Zhou H, Ding H et al (2003) An enhanced U6 promoter for synthesis of short hairpin RNA. Nucl Acids Res 31:e100CrossRefPubMedGoogle Scholar
  27. Ying S-Y, Lin S-L (2009) Intron-{Mediated} {RNA} {Interference} and {microRNA} {Biogenesis}. Methods Mol Biol 487:387–413PubMedGoogle Scholar
  28. Yuan J, Wang X, Zhang Y et al (2006a) Mammalian Pol III promoter H1 can transcribe shRNA inducing RNAi in chicken cells. Mol Biol Rep 33:33–41CrossRefPubMedGoogle Scholar
  29. Yuan J, Wang X, Zhang Y et al (2006b) shRNA transcribed by RNA Pol II promoter induce RNA interference in mammalian cell. Mol Biol Rep 33:43–49CrossRefPubMedGoogle Scholar
  30. Zhou H, Xia XG, Xu Z (2005) An RNA polymerase II construct synthesizes short-hairpin RNA with a quantitative indicator and mediates highly efficient RNAi. Nucl Acids Res 33:1–8CrossRefGoogle Scholar
  31. Zou GM, Wu W, Chen J, Rowley JD (2003) Duplexes of 21-nucleotide RNAs mediate RNA interference in differentiated mouse ES cells. Biol Cell 95:365–371CrossRefPubMedGoogle Scholar

Copyright information

© The Genetics Society of Korea 2019

Authors and Affiliations

  1. 1.Department of Molecular Bioscience, College of Biomedical ScienceKangwon National UniversityChuncheonRepublic of Korea
  2. 2.Division of Biomedical Convergence, College of Biomedical ScienceKangwon National UniversityChuncheonRepublic of Korea

Personalised recommendations